Matches in Wikidata for { <http://www.wikidata.org/entity/Q90692551> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q90692551 description "clinical trial" @default.
- Q90692551 description "ensayo clínico" @default.
- Q90692551 description "ensayu clínicu" @default.
- Q90692551 description "klinisch onderzoek" @default.
- Q90692551 description "клінічне випробування" @default.
- Q90692551 name "Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma" @default.
- Q90692551 name "Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma" @default.
- Q90692551 type Item @default.
- Q90692551 label "Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma" @default.
- Q90692551 label "Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma" @default.
- Q90692551 prefLabel "Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma" @default.
- Q90692551 prefLabel "Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma" @default.
- Q90692551 P1050 Q90692551-91E2A23C-17FF-45DD-8786-586F773715F5 @default.
- Q90692551 P1132 Q90692551-8BF26BB2-7132-4365-ABC9-5A74F03BBB9C @default.
- Q90692551 P1476 Q90692551-AE113CD8-B7A0-4567-AD26-A00963E2046E @default.
- Q90692551 P2899 Q90692551-D1447D79-48A7-4C81-9F0F-6969A948FCFC @default.
- Q90692551 P3098 Q90692551-7B6310E0-ADBE-4810-9672-F5C4456E4DB6 @default.
- Q90692551 P31 Q90692551-B62B3ED6-39B2-438A-9789-6D3EDDFC6B99 @default.
- Q90692551 P580 Q90692551-BEE409BB-C899-4135-91C0-D6B2CC1F4D0B @default.
- Q90692551 P582 Q90692551-52110960-61EF-4DA8-8AF0-03E42D374DB1 @default.
- Q90692551 P6099 Q90692551-B76C3B17-CF2B-48C6-BA6E-87BC659BF992 @default.
- Q90692551 P8363 Q90692551-2F3C3048-F4D5-4E7B-89B9-C32CF9EB0164 @default.
- Q90692551 P1050 Q208414 @default.
- Q90692551 P1132 "+56" @default.
- Q90692551 P1476 "A Randomized,Open-label Phase III Study of Camrelizumab (SHR-1210) vs. Investigator's Choice of Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)" @default.
- Q90692551 P2899 "+18" @default.
- Q90692551 P3098 "NCT04342936" @default.
- Q90692551 P31 Q30612 @default.
- Q90692551 P580 "2020-05-25T00:00:00Z" @default.
- Q90692551 P582 "2023-08-01T00:00:00Z" @default.
- Q90692551 P6099 Q42824827 @default.
- Q90692551 P8363 Q78089383 @default.